The plasmid pBS-G-ΦT encodes the vesicular stomatitis virus (VSV) glycoprotein (G) from the Indiana serotype expressed from the bacteriophage T7 promoter in pBS, which has been further modified to contain a T7 terminator sequence cloned between the SacII and SacI restriction sites in pBS-SK+ [1]. The plasmid is used as part of the VSV reverse genetics system to recover replication-restricted ΔG-VSV from plasmids [2]. The recovery of ΔG-VSV involves the transfection of cells that have been infected with recombinant vaccinia expressing bacteriophage T7 RNA polymerase (vvT7) with 5 different plasmids; one which expresses the ΔG-VSV antigenomic-sense (or positive-sense) RNA and 4 other plasmids that encode individually the VSV N, P, G and L proteins, all of which are under control of T7 promoters.
From the laboratory of Michael A. Whitt, Ph.D., University of Tennessee.
Part of The Investigator's Annexe program.
Product Type: | Plasmid |
Gene/insert name: | VSV-Indiana glycoprotein (G) |
Accession ID: | P03522 |
Antibiotic Resistance: | Ampicillin or Kanamycin (please see vial label and packing slip) |
Fusion Tag(s): | none |
Concentration: | 100uL (100ng/uL) |
Grow in E. coli at 37 C: | Yes |
Cloning Site 5': | ApaI |
Cloning Site 3': | BamHI |
Insert Size: | 1,700 bp |
Vector Backbone and Size: | pBS-SK-ΦT, 3105 bp |
High or low copy: | High |
Comments: | For suggested protocol, see: Whitt, MA, J. Virol. Methods, 2010. 169(2): p. 365-74. |
Shipped: | Ambient temperature |
If you publish research with this product, please let us know so we can cite your paper.